Comparative Effectiveness of Denosumab versus Alendronate Among Postmenopausal Women with Osteoporosis in the US Medicare Program

被引：0
|
作者：
Curtis, Jeffrey [1 ]
Arora, Tarun [2 ]
Liu, Ye [1 ]
Lin, Tzu-Chieh [3 ]
Spangler, Leslie [3 ]
Brunetti, Vanessa C. [3 ]
Stad, Robert K. [3 ]
McDermott, Michele [3 ]
Bradbury, Brian D. [3 ]
Kim, Min [3 ]
机构：
[1] Univ Alabama Birmingham, Birmingham, AL USA
[2] Fdn Adv Sci Technol Educ & Res, Birmingham, AL USA
[3] Amgen Inc, Thousand Oaks, CA USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2023年 / 75卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2008
引用
收藏
页码：3979 / 3981
页数：3
相关论文
共 50 条
  • [31] Denosumab versus romosozumab for postmenopausal osteoporosis treatment
    Kobayakawa, Tomonori
    Miyazaki, Akiko
    Saito, Makoto
    Suzuki, Takako
    Takahashi, Jun
    Nakamura, Yukio
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [32] Denosumab versus romosozumab for postmenopausal osteoporosis treatment
    Tomonori Kobayakawa
    Akiko Miyazaki
    Makoto Saito
    Takako Suzuki
    Jun Takahashi
    Yukio Nakamura
    Scientific Reports, 11
  • [33] Isosorbide mononitrate versus alendronate for postmenopausal osteoporosis
    Nabhan, Ashraf F.
    Rabie, Noha H.
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2008, 103 (03) : 213 - 216
  • [34] Denosumab: an antifracture therapy for postmenopausal women with osteoporosis
    Jiang, Xuezhi
    Schnatz, Peter F.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2013, 20 (02): : 117 - 119
  • [35] Comparison of alendronate and raloxifene in postmenopausal women with osteoporosis
    Sanad, Z.
    Ellakwa, H.
    Desouky, B.
    CLIMACTERIC, 2011, 14 (03) : 369 - 377
  • [36] Update on Denosumab Treatment in Postmenopausal Women with Osteoporosis
    Min, Yong-Ki
    ENDOCRINOLOGY AND METABOLISM, 2015, 30 (01) : 19 - 26
  • [37] Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
    Cummings, Steven R.
    San Martin, Javier
    McClung, Michael R.
    Siris, Ethel S.
    Eastell, Richard
    Reid, Ian R.
    Delmas, Pierre
    Zoog, Holly B.
    Austin, Matt
    Wang, Andrea
    Kutilek, Stepan
    Adami, Silvano
    Zanchetta, Jose
    Libanati, Cesar
    Siddhanti, Suresh
    Christiansen, Claus
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (08): : 756 - 765
  • [38] Denosumab treatment in postmenopausal women with osteoporosis reply
    Bone, Henry G.
    Wagman, Rachel B.
    Pannacciulli, Nicola
    Papapoulos, Socrates
    LANCET DIABETES & ENDOCRINOLOGY, 2017, 5 (10): : 768 - 769
  • [39] DENOSUMAB FOR PREVENTION OF FRACTURES IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS
    Tofilovska, S. T. J.
    Prosheva, T. B. P. Bajraktarova
    Jordanova, S. J.
    OSTEOPOROSIS INTERNATIONAL, 2018, 29 : S457 - S458
  • [40] Comparison of clinical efficacy and safety between denosumab and alendronate in postmenopausal women with osteoporosis: a meta-analysis
    Lin, T.
    Wang, C.
    Cai, X. -Z.
    Zhao, X.
    Shi, M. -M.
    Ying, Z. -M.
    Yuan, F. -Z.
    Guo, C.
    Yan, S. -G.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2012, 66 (04) : 399 - 408
12345